EE571 Cost-Effectiveness of Maribavir for Post-Transplant Refractory Cytomegalovirus Infection With or Without Resistan A UK Perspective

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.811
https://www.valueinhealthjournal.com/article/S1098-3015(22)03015-7/fulltext
Title : EE571 Cost-Effectiveness of Maribavir for Post-Transplant Refractory Cytomegalovirus Infection With or Without Resistan A UK Perspective
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03015-7&doi=10.1016/j.jval.2022.09.811
First page :
Section Title :
Open access? : No
Section Order : 10351
Categories :
Tags :
Regions :
ViH Article Tags :